Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
labmedica.com
Clinical Chemistry
Features Subscription Partner Sites Journal Info
RANDOX LABORATORIESSIEMENS HEALTHCARELEICA WETZLAR-GERMANY

Early Detection of Intrahepatic Cholangiocarcinoma Crucial

By Labmedica International staff writers
Posted on 27 Jan 2010


Incidence of intrahepatic cholangiocarcinoma (ICC) is increasing worldwide and its prognosis is very poor. Therefore, further studies on its clinical characteristics for early detection and on surgical treatment for better prognosis are urgently needed.

A research team from the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China) retrospectively evaluated 5,311 liver cancer patients who received resection between October 1999 and December 2003. Of these, 429 (8.1%) patients were diagnosed with ICC, and their clinicopathologic, surgical, and survival characteristics were analyzed. Their study was published on December 21, 2009, in the World Journal of Gastroenterology.

The study demonstrated that hepatitis B infection, carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), and alpha-fetoprotein (AFP) are associated with ICC development. CA19-9 levels are associated with lymph node metastases, but inversely with cirrhosis. Radical resection (R0) is the key prognostic factor for ICC.

Future studies, according to the researchers, should focus on evaluation of the molecule-targeted therapy, and whether it can effectively control this lethal disease to improve the survival of the patients.

Related Links:

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University






Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?




HbA1c Analyzer
HbA1c Analyzer
Blood Collection Set
Blood Collection Set
Chemistry Analyzer
Chemistry Analyzer

More Products

Latest Clinical Chemistry News

Latest Issue
View Digital Edition
Subscribe / Renew
Alere
LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured MedBiz Market Reports
Premium Report Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Premium Report Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Featured Whitepaper
SIEMENS DIAGNOSTICS :
TRUGENE HBV Genotyping Assay

Download Whitepaper
Events
Romanian Society of Laboratory Medicine (RSML) Congress
08 Sep 2010
10 Sep 2010


Analytica China 2010
15 Sep 2010
17 Sep 2010


Annual Meeting of the Swiss Society of Clinical Chemistry
15 Sep 2010
17 Sep 2010


More events
MINDRAY-LAB
FOCUS DIAGNOSTICS, INC.
INSTRUMENTATION LAB
DRG INTERNATIONAL, INC.
GLOBETECH PUBLISHING
QBC Diagnostic
AACC
THE BINDING SITE
  labmedica.com Copyright � 2000-2010 Globetech Media. All rights reserved.